The effect of hyper-tonic saline serum on the outcome of patients with severe stroke
Phase 3
Recruiting
- Conditions
- Sever Ischemic stroke.
- Registration Number
- IRCT20190311043008N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Moderate to severe ischemic stroke
Age between 18 and 80 years
Agreed to participate in the study
No previous use of hyper-tonic saline and other serums in the last month before the onset of symptoms
Hospitalized in the neurology ward of Shahid Beheshti Hospital,
Exclusion Criteria
Having a previous serious chronic disease that interferes with the functional evaluation of patients, such as cancers,
Liver ? kidney ? heart failure,
Chronic infection
Dissatisfaction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death. Timepoint: During Hospitalization. Method of measurement: Physician diagnosis.;Patient recovery in quarterly follow-up. Timepoint: Before starting treatment on days 5, 10, 30 and three months after starting treatment with hyper-tonic saline. Method of measurement: The initial checklist form includes: type of stroke, frequency of stroke, risk factors and clinical scoring score based on the National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (MRS).
- Secondary Outcome Measures
Name Time Method